Transaction Data Systems (TDS), parent company of the Rx30 and Computer-Rx pharmacy management systems, today publicly announced the acquisition of Pharm Assess, Inc. and its Retail Business Solutions product suite (RBS).
| OCOEE, Fla., April 4, 2019 /PRNewswire/ -- Transaction Data Systems (TDS), parent company of the Rx30 and Computer-Rx pharmacy management systems, today publicly announced the acquisition of Pharm Assess, Inc. and its Retail Business Solutions product suite (RBS). Pharm Assess RBS offers comprehensive business solutions that drive profitability at the pharmacies by supporting compliance with pharmacy and staff credentialing and providing audit assistance, third party payer contract assistance, financial reporting, 340B program assistance and much more.
The Pharm Assess Retail Business Solutions will be integrated with the other TDS technologies and will provide comprehensive business solutions to independent and community pharmacies. RBS technologies and programs will be available any community pharmacy—TDS platform users, as well as community pharmacies utilizing non-TDS pharmacy management systems. TDS’ Rx30 and Computer-Rx customers will have access to all programs and services offered through the RBS menu. The technology and services can be bundled, with several options available a la carte. Product and service options include:
“Our pharmacist-owned and operated comprehensive retail business solution (RBS) offering incorporates over 20 years of experience working closely with pharmacy owners,” stated Monty Rogers, R.Ph., President and owner of Pharm Assess, Inc. “Independent and community pharmacies need their key vendors to be experienced and readily available business partners in this fast-pace and ever-changing industry. With this acquisition, I’m glad we will be able to deeply integrate our program with the TDS platforms to bring enormous scale in making affordable real-time business solutions available to independent and community pharmacy businesses.” “TDS is excited to announce this acquisition. Pharm Assess and Monty Rogers will bring valuable insight gained from 20 years of experience in our industry, where Monty has worked side-by-side with independent and community pharmacies for decades,” said Jude Dieterman, TDS CEO. “Monty’s experience with business solutions, managed care and third-party payer contracts will bring substantial knowledge to the TDS strategic roadmap as we continue to bring technology and innovation to our clients.” About Pharm Assess, Inc. About Transaction Data Systems (TDS)
SOURCE Transaction Data Systems |
View original content to download multimedia:
